A new drug target for liver cancer

If healthy people are purposefully infected with COVID-19 for the sake of science, they should be paid
5 February 2021
Physician, heal thyself? Leaving healers at risk of covid-19 is unacceptable
5 February 2021

A new drug target for liver cancer

National University of Singapore researchers have discovered that the MOAP-1 protein plays a role in reducing liver cancer risk by suppressing the hyper-active cancer-promoting Nrf2 cellular signaling pathway.

Comments are closed.